Georgia vs Nicaragua: HIV/AIDS deaths averted by antiretroviral therapy
Georgia
391.52 deaths
in 2024
Nicaragua
333 deaths
in 2022
Georgia rank
97th
Nicaragua rank
100th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Georgia
- Nicaragua
How they compare
Georgia currently reports 391.52 deaths against 333 deaths in Nicaragua, a difference of 58.52 deaths.
That makes Georgia's figure about 1.2 times Nicaragua's.
The two have swapped places 1 time across 33 shared years of data; in 1990 it was Nicaragua ahead.
Georgia ranks 97th and Nicaragua ranks 100th of 157 countries.
Nicaragua has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Georgia | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 21.22 deaths | 55.8 deaths | 34.58 deaths | Nicaragua |
| 2010s | 188.92 deaths | 288.7 deaths | 99.78 deaths | Nicaragua |
| 2020s | 343.87 deaths | 346 deaths | 2.13 deaths | Nicaragua |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Georgia or Nicaragua?
- Georgia, at 391.52 deaths against 333 deaths in Nicaragua as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Georgia and Nicaragua?
- 58.52 deaths, with Georgia ahead.
- How many years of comparable data are there for Georgia and Nicaragua?
- 33 years are reported by both, from 1990 to 2022.
- How do Georgia and Nicaragua rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Georgia ranks 97th and Nicaragua ranks 100th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.